MBA, Ph.D., Associate Director, Strategic Sourcing, Biogen
Shiva Krupa is the Associate Director for R&D Preclinical Strategic Souring at Biogen. In this role, Dr. Krupa is responsible for strategy and execution of outsourced preclinical services. She is also responsible for developing the procurement strategy for Human Biospecimens. In her previous roles, Dr. Krupa was the External Alliance and Project Manager at Novartis.
Risks of Human Biospecimen Acquisition – Industry Perspective
Biopharma’s define the acquisition of human biospecimens as a high-risk sourcing activity. We look at the risks, from an industry perspective, of acquiring biospecimens to increase awareness so that we begin to address the blockers of successful biopharma-provider relationships.
Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Pharma’s define the acquisition of human biospecimens as a very high-risk sourcing activity. This session looks at the risks and challenges, from an industry perspective, of acquiring samples and introduces a solution to remove the barriers, administrative burden, and reduce the cost for both Pharma’s and providers of samples.